Ovarian function after chemotherapy in young breast cancer survivors.

Morarji, K; McArdle, O; Hui, K; Gingras-Hill, G; Ahmed, S; Greenblatt, E M; Warner, E; Sridhar, S; Ali, A M F; Azad, A; Hodgson, D C

Morarji, K; McArdle, O; Hui, K; Gingras-Hill, G; Ahmed, S; Greenblatt, E M; Warner, E; Sridhar, S; Ali, A M F; Azad, A; Hodgson, D C.

Afiliación

Morarji K; Department of Radiation Oncology, Princess Margaret Hospital.
McArdle O; Department of Radiation Oncology, Princess Margaret Hospital.
Hui K; Department of Radiation Oncology, Princess Margaret Hospital.
Gingras-Hill G; Department of Radiation Oncology, Princess Margaret Hospital.
Ahmed S; Department of Radiation Oncology, Princess Margaret Hospital.
Greenblatt EM; Department of Obstetrics and Gynecology, Mount Sinai Hospital.
Warner E; University of Toronto.
Sridhar S; Department of Medical Oncology, Odette Cancer Centre.
Ali AMF; Department of Medical Oncology, Princess Margaret Hospital; and.
Azad A; Department of Medical Oncology, Odette Cancer Centre.
Hodgson DC; Pathology and Laboratory Medicine Unit, Mount Sinai Hospital, Toronto, ON.

Curr Oncol ; 24(6): e494-e502, 2017 Dec.

Article en En | MEDLINE | ID: mdl-29270058

Palabras clave

Anti-Müllerian hormone; breast cancer survivors; chemotherapy; ovarian reserve

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Curr Oncol Año: 2017 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google